It has been shown that nocodazole and CDK1 inhibitors, but not lovastatin, could cause cell cycle blockade accompanied by increased expression of HLA-G and PD-L1, which impaired the killing effect of immune cells against tumor cells [232]. Here, HLA-G is linked to neoplasm.